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Panel Discussion: Role of High Risk
Groups in the Derivation of
Environmental Health Standards
Lawrence Plumlee*
We have heard a great many points reiterated,
and I've tried to figure out some ideas that might
have been missed. One thing is that some of us will
go back into environments where standards for en-
vironmental contaminants are set. We must try to
be cautious and not forget how ignorant we are.
We have heard the description of a variety of
syndromes which lead to hypersusceptibility. These
include groups which are especially exposed to high
levels of chemicals; groups which are deficient in
nutrients; and groups which are genetically predis-
posed to environmental chemical sensitivities. Thus
we have the feeling that we know more-and we
probably do-than most of our colleagues back
home about hypersusceptibility. I think it is very
important for us to remember though that there are
enormous numbers ofdiseases ofunknown etiology
which may well have at least some etiological basis
in environmental chemicals. There is increasing
evidence that not only cancer but heart disease and
many of the autoimmune diseases like rheumatoid
arthritis, ulcerative colitis, regional enteritis, as well
as respiratory diseases and even behavioral disor-
ders and serious mental disorders, may be related in
part to environmental chemicals. Even with the
knowledge that we may have of hypersusceptible
groups, I think that you should keep in mind Dr.
Barth's opening remarks. We may still not yet know
the major causes of environmental diseases. We
may not have identified those most susceptible to
environmental chemicals, either because they have
illnesses which are caused by ubiquitous environ-
mental chemicals or because we fail to realize that
specific pre-existing diseases have made certain in-
dividuals more susceptible to environmental chemi-
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cals. This means, of course, that the old-fashioned
safety factor in setting standards may not be obso-
lete.
In recent years, particularly in the area of car-
cinogenesis we've been attempting at EPA to follow
an interim policy which attempts to estimate the
risk ofthe carcinogens to human populations so that
these risk estimates can be used in risk benefit
analyses. Open use of such analyses for setting en-
vironmental standards represents a relatively new
development, as are congressional mandates to
carry them out. I think probably, to some extent or
another, risk-benefit analyses always have taken
place in the setting of environmental standards,
even though the language that was used to describe
to the public what was taking place was that the
levels that were being promulgated represented
- safe" levels. This may not be dishonest. Paul
Kotin mentioned this morning that safety does not
necessarily mean absolute safety. When the Clean
Air Act Amendments of 1970 were passed, there
was a rather specific Congressional mandate to set
the standards to protect the public health with a
margin of safety, and the Congressional reports of
the time reiterated that the margin of safety should
protect high risk groups such as those with respira-
tory and chronic diseases. Certainly a review ofthe
criteria used for EPA's 1971 Ambient Air Quality
Standards, as well as recent reviews of research
being considered when rewriting the Air Quality
Criteria Documents, reveals that a great deal ofem-
phasis has been given to studying high risk groups
as well as the general population. These high risk
groups have varied with the study ofangina patients
and persons with cardiac disabilities in the case of
criteria for carbon monoxide to the arousal ofrespi-
ratory symptoms in populations of asthmatics,
chronic bronchitics, aged persons or infants in the
case of nitrogen oxides, oxidants, sulfates, and
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Since the Clean Air Act Amendments of 1970,
some new features have been introduced into laws.
For example, 1972 amendments to the Federal In-
secticide, Fungicide and Rodenticide Act (FIFRA),
and the Toxic Substances Control Act of 1976
(TSCA), both use language that requires EPA to
carry out risk-benefit analyses. These laws for the
most part did not address standards by using the
word "safety." Rather, concepts ofrisk were cited.
To describe the risk of chemicals to a population,
one would obviously have to understand the effect
on hypersusceptibles as well. So these laws lead to
involvement ofthe political process: the decision of
weighing the risks, which health personnel would be
instrumental in formulating, with the benefits which
presumably would be formulated more by
economists and politicians. In fact, this isn't en-
tirely so. We as environmental health scientists are
certainly aware ofthe work from the Johns Hopkins
School of Public Health in the last few years show-
ing the high incidence of suicide, depression, and
cardiovascular disease related to unemployment.
So we can appreciate that the trade-offs are not all
between health and economics, but there are health
components that are intimately related to the
economic factors. A study of hypersusceptible
groups by our environmental agencies need not be a
".cop out" in terms of seeking to find ways of
excluding such groups from protection. Rather, it is
an awareness ofthe adverse effects ofchemicals on
hypersusceptible groups which permits us to con-
sider such groups in the standard setting process.
Earlier I urged that safety factors probably were
still necessary because we might be only at the in-
fancy ofunderstanding the total effects ofchemicals
on human health. Nevertheless, we have to con-
tinue to increase our data base in order to be sure
that our criteria are more accurate.
Another area ofcontroversy that has come up has
to do with the responsibility of the physician and
environmental health scientist, whether he works
for the government or for industry to take a stand
for health. With the division of labor related to
cost-benefit analysis in the derivation of environ-
mental standards under TSCA and FIFRA, it might
be thought that the physician's role has ended when
he has defined the health risk, and that he can then
step aside and let the lawyer-administrator and
other decision makers decide how to weigh these
risks and benefits. But I think it is again clear to us,
because we recognize our own ignorance, that we
must help our administrators, who are generally not
* EPA Office of Air Quality Planning and Standards.
environmental health scientists but politicians and
management specialists. We must help these indi-
viduals to understand our lack of knowledge. In-
creasingly, we're having to make decisions about
chemicals that may have long-term adverse affects
on the basis of a limited amount of animal data,
largely because prudence dictates that we not ex-
pose individuals to animal carcinogens for several
decades in order to find out whether or not they
may turn out to be human carcinogens. Often we
are dealing withjust a few studies, even though they
may be consistent, and a safety factor may be
necessary because of lack of information available
at the time when a decision appears prudent. Yet it
is the duty ofthe environmental health scientists to
provide to the decision maker with the best in-
terpretation possible from such limited data.
The final point is: in setting standards for en-
vironmental contaminants, we must be aware that
high risk groups are not a small portion of the
population. We've often traditionally set standards
by using safety factors of 100 below the no-effect
levels of a pesticide which was given to a group of
50 mice; a food tolerance might be derived based on
a safety factor of 100 below the no-effect level on
such a feeding study. A factor of 100 may well be
too small. We must remember that all embryos,
fetuses, and neonates up to the age of about two or
three months have immature enzyme detoxification
systems; that infants and children don't reach ma-
ture levels ofimmunoglobulin A until they reach the
ages of 10 to 12; that as we age, our immune system
becomes less functional, making us more sensitive
to carcinogens and respiratory irritants; that infants
may be more susceptible because of increased ab-
sorption ofpollutants as a function oftheir age; that
retention of pollutants such as fluoride might be
more common in individuals over the age of50; that
there are, after all, enormous numbers of pregnant
women in our population who are more sensitive to
chlorinated hydrocarbon insecticides, lead, and
carbon monoxide; that every one of us have our
susceptible times during the day because of circa-
dian rhythms; and we've heard ofcourse a lot about
other factors, nutritional and genetic. Hypersus-
ceptible groups are consequently not rare
phenomena but include virtually everyone in the
population from time to time.
Stanton Coerr*
In my view, we are already using information
about high risk populations in formulating environ-
mental regulations. I would like to talk about some
of the issues that confront us in dealing with high
risk groups.
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and Standards try to do is match the scientific data
base provided to us by the scientific community
with what is required ofus as an Agency by the laws
under which we are operating. My specific experi-
ence is in drafting a proposed national air quality
standard for lead. I am now working on the short-
term NO2 standard.
We are coming under increasing pressure to ap-
proach air standards in a consistent fashion-in
other words, that the societal risk for high-risk
groups exposed to ozone, NO2, or lead be treated in
comparable terms. I think this is good in some ways
and not so good in other ways. There are situations
in which you wish to keep specific flexibility to deal
with what is unique to each pollutant, and other
cases in which you wish to borrow some of the ac-
cepted approach of another standard.
Another problem we face is how many tiers of
subgroups we consider in attempting to come up
with a numerical level for a standard before we
throw ourselves into margin of safetyjudgments. In
the case of the lead standard, there were a number
of candidate groups, principally small children and
pregnant women, which for a variety of reasons
could be regarded as sensitive. In addition to gen-
eral sensitivity, certain children could also be seen
as having genetic deficiencies, a deficient diet situ-
ation, or an exposure situation which would place
them into a more sensitive subgroup than the gen-
eral population. In the NO2 short-term standard,
most ofthe chamber work has been on adult volun-
teers, either bronchitic or normal, and we are aware
of the fact that there might be more sensitivity in
elderly or younger individuals, but we have no ex-
perimental data. Ourgeneral rule ofthumb on this is
that as long as we deal with groups in the general
population of some significant size, we will deter-
mine the numerical thresholds for effects down to
the point at which we no longer have data. After
that point, we are left with qualitative estimation
that there may be more effects for a certain group.
We then tend to use margin of safety.
There is more than one way to treat sensitive
groups. For example in the lead standard. We are
using small children, as the sensitive population;
instead of trying to move down to a more sensitive
subgroup (those in the center city or children who
are nutritionally at more risk), because we have
good numbers on the statistical distribution ofblood
lead for a population of children, we can do some
statistical work in estimating the mean blood lead at
which a certain number ofchildren or a certain per-
centage of children are below a given threshold
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level.
When we get into lead, which is a multi-media,
multi-source pollutant, we get ourselves into all
kinds of tangles in trying to define what we would
regard as a sensitive population with regard to air
exposure alone. For example, we could with a cer-
tain amount of affection or compassion regard
people who distill their own whiskey in radiators as
being a sensitive population because they are very
much lead-exposed. It's not clear, though, that the
air standard should attempt to address that particu-
lar group.
I am aware that as we move from the scientific
data base into regulatory judgments that relate to
choosing sensitive populations and the thresholds
for adverse effects and acceptable risk, we move
away from the scientific principles about what is
scientifically valid, to the principles of the regulat-
ory world which are more those of the lawyer.
When you take scientists away from the database in
dealing with validity into the regulatory world
where validity is established through debate, you
will get different kinds of answers about sensitive
populations. Scientists are not comfortable moving
into regulatory debates and they prefer not to
speculate about risk in quite the same way as reg-
ulators.
Herbert L. Needleman*
In the brief time allotted, I shall try to address
only two points: (I) the definition of '"adverse
health effect'" in the context ofcontemporary medi-
cal practice; (2) recent studies of my group at Har-
vard Medical School which support the assertion
that the threshold for adverse health effects is at
least an inverse function of the sensitivity of the
methods brought to bear. I shall use low level lead
exposure as the model.
Recently, the Center for Disease Control issued a
revised health standard on preventing childhood
lead poisoning. This set the limit for undue lead
exposure at 20 ,ug/dl. CDC found evidence to sup-
port this limit in the finding by Dr. Piomelli and
others that free erythrocyte protoporphyrin (FEP)
begins to rise at blood lead levels somewhere below
30 ,g/dl, perhaps as low as 15 ,g/dl. The lead in-
dustry has taken the position that an elevated FEP
is not an adverse health effect; it is purely a
biochemical change. This position, is in fact, the
center of the industry's stance in regard to the Air
Lead Criteria Document.
As a practicing physician I find myself called
upon to make diagnostic and therapeutic judge-
ments on the basis of incomplete data with regular-
ity. Physicians generally employ early biochemical
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list three examples where medical judgements are
made which always cost money and frequently en-
tail risk or discomfort. These judgements are made
on the basis ofbiochemical changes which are not in
themselves the essential disease state.
If a patient has a Kaiser-Fleischer Ring in the iris
or an abnormal serum copper and a family history of
Wilson's Disease, a prudent physician will commit
that patient to penicillamine therapy, probably for
the rest of his life.
If a child is born to a mother with a history of Rh
incompatibility, has a positive Coombs test and a
bilirubin greater than 5 mg, an exchange transfusion
would be performed.
A child whose tuberculin reaction has converted
within the past year would be placed on antituber-
culous therapy, even though the skin reaction is
simply a collection of the immune chemicals and is
not in itself threatening to the child.
Not to respond to the above biochemical changes
is to run the risk of malpractice. I am comfortable
with an elevated FEP as an adverse health effect. I
do not think it is the core of the Air Lead Standard,
but is certainly a helpful index to action.
I should like to comment on the recent work of
my own group on the subject of neuropsychologic
outcome in children at low doses of lead. I do not
think low dose is the right phrase: unidentified lead
intoxication is probably more precise.
In Boston we have been examining the neurop-
sychologic performance of first and second graders
considered asymptomatic for lead who differ with
respect to the concentration of lead in their decidu-
ous teeth. It seems quite clear that the high dentine
lead group have a mean IQ about 6 points below
that of the low lead group. I recently presented this
datum at the Society for Pediatric Research and was
approached by a professor of pharmacology who
asked me if I considered a 6 point difference in IQ of
enough importance to warrant spending a great deal
of money. I was and remain startled by this ques-
tion.
Let me review our study briefly. We collected
shed deciduous teeth from 75% of all first and sec-
ond graders in Somerville and Chelsea, Mas-
sachusetts, and analyzed them for lead. We then
excluded from the first analysis any child with a
history of lead intoxication, low birth weight, or
head injury, and brought in to the neuropsychologic
clinic under strict double blind conditions children
in the highest and lowest 20th percentiles for de-
ntine lead. We controlled for 20 nonlead variables
such as socioeconomic status, parental IQ, and
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health history. We found that of 37 outcomes mea-
sured, the high lead group showed significant def-
icits (well below p = 0.05) on 14 measures. This
study has been completed, and we are persuaded
that lead at low dose does produce adverse health
effects.
If we were to set the lead standard low enough to
protect 95% ofthe population, that would appear at
first to be acceptable performance. However, there
are 17 million children under six years of age in this
country. Protecting 95% from hazardous lead expo-
sure would allow 850,000 to be at risk for brain
damage. That clearly is not acceptable for any soci-
ety which wishes to be remembered as authentically
concerned about the welfare of its children.
Roy Albert
Let's begin on a note of confusion in talking about
the regulation of environmental carcinogens. The
confusion deals with the concept of hypersuscepti-
bility and how this relates to normal responses to
carcinogens, and how these concepts in turn bear
on our regulatory policies and of the nature of low
level responses to carcinogens. I might say that the
regulation of environmental carcinogens is still in a
state of flux, particularly what constitutes an ap-
propriate level of control- in other words, how se-
vere the control of environmental carcinogens
should be. There has been an explosive growth in
the concern about regulating environmental car-
cinogens because of the demonstrated importance
ofenvironmental factors and the lack ofsatisfactory
treatment of cancer. The dominant conceptual fea-
ture of the regulatory landscape at the present time
is the linear nonthreshold dose-response relation-
ship. The first surfaced in the 1950's during the de-
bate about the health hazards, particularly cancer-
hazards from atomic fall-out from weapons testing.
Data on Japanese survivors of the atomic bombing
on leukemia suggested the consistency of the dose-
response relationship with the linear nonthreshold
dose response pattern. The support for the exis-
tence of this sort of a response pattern comes trom
the fact that it holds for the mutagenic action of
ionizing radiation and chemical carcinogens and
that there is a strong relationship between
mutagenicity and carcinogenicity. The essence of
the nonthreshold relationship is that no matter- how
small the dose, there is always a finite excess cancer
risk. There is no such thing as a safe dose of car-
cinogen. This was translated in the late 50's into the
Delaney Clause of the Food and Drug Act, which
bans any agents as a food additive which show car-
cinogenic effects.
With the growth in the concern for the control of
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that many agents cannot be banned: they are simply
too important. And, as I mentioned, it is unclear
what constitutes a satisfactory level of control. We
know that there are hypersusceptible responders to
carcinogens. One only has only to look at the situa-
tion with skin cancer induced by sunlight. It is es-
sentially not a problem of heavily pigmented
people. There is a considerably greater susceptibil-
ity among individuals that have fair skin, freckled
complexions, red hair, generally of Celtic origin.
Then at the far extreme ofthe spectrum ofsuscepti-
bility, are the diseased individuals (xeroderma pig-
mentosum) who have a defect in their ability to re-
pair DNA. Hypersusceptibility to sunlight-induced
skin cancer thus has two components. One relates
to the effective dose, namely the relative lack of
pigmentation, and the second involves a defect in
the underlying process of repair. Here, the under-
lying concept of hypersusceptibility is that suscep-
tibility is a continuum and hypersusceptibles are at
one end of the spectrum. It should be possible to
protect everyone if the dose is sufficiently low.
A linear nonthreshold dose-response pattern,
however, can imply a different concept, namely the
probabilistic notion of a single-hit process. Getting
cancer at very low levels of exposure to a carcino-
gen is like getting hit by a meteor. There is no need
to invoke hypersusceptibility; it isjust a mistake in
DNA repair, like having a glass of water slip out of
your hand. So we have two competing points of
view. One is the notion ofa probabilistic occurrence
ofa mistake in DNA repair in contrast to the notion
that there are innate biological factors which exag-
gerate the response to carcinogens. There are very
General Discussion
DR. SENKER (Newt, England Medical Center): I'd like to ask
what is considered the significance in determining ambient air
quality standards of childhood exposures and the relation that
childhood exposures may have later on, particularly on pulmo-
nary functions. Where should this fit into the setting of stan-
dards, given the difficulty in experimental situations or in, even
determining the effect?
DR. NEEDLEMAN: I don't advertise myself as having any
particular competence in the area of pulmonary disease. I do
think that the issue ofambient air quality standards with respect
to child health is a vital one. With regard to brain development,
the studies of my group done in Philadelphia showed that chil-
dren who lived in good housing but adjacent to lead industry had
dentine lead levels as high as those in the center ofthe lead belt
ofPhiladelphia. Dust levels in the school attended by these chil-
dren reached as high as 5000 ppm. The latent effects of early
exposure on later disability, whether pulmonary or neurologic,
are ofgreat importance. I think we spend an enormous amount of
significant theoretical and practical consequences
of these two points of view. One is that if you are
talking hypersusceptibility, you are talking about
deterministic concept where everybody is on a
track toward getting cancer sooner or later. The
speed at which you progress toward getting cancer
is related to the level of exposure and your suscep-
tibility. This notion conveys the idea that there is a
threshold in time: therefore if exposure is suffi-
ciently low enough for any given level of suscepti-
bility, cancer will not develop before the end of the
normal lifespan.
The probabilistic approach, which implies a
chance mechanism, is different in the sense that the
time pattern of cancer occurrence is built into the
biological processes and that the level of exposure
determines the probability of cancer at any given
time. So there is no real shift in time occurrence and
there is no such thing as the time threshold.
At the present time, we are appearing to be
locked into the probabilistic linear nonthreshold
dose response, although the evidence for it is still
quite scanty. The consequences of it are that one
seeks to control exposure to extraordinarily low
lcvels; that is, lifetime excess risk of more than one
chance in a hundred thousand or one chance in a
million or even less than that is not tolerable. And
so we have the interesting circumstance that a con-
ceptual point of view about normal patterns of re-
sponse has fixed us into a mode of controlling car-
cinogens which is extraordinarily strict by any stan-
dard, and probably stricter than what we generally
conceive of as the level of exposure required to
control the response of hypersusceptibles.
money on things like orthodonture and elocution lessons and
ignore the development of our children's brains.
DR. CARL SHY: There are some British studies on cohorts of
children that do suggest that the frequency ofrespiratory disease
in childhood is a risk factor for the development of obstructive
lung disease in adulthood. There is also the other association
between air pollution exposure and increased frequency ofacute
respiratory disease in childhood. But wejust don't have much in
the way of longitudinal data to answer your question.
MARVIN KAUHKSTEIN (Science for the People): I'd like to
address my question to anyone who may be involved in drafting
regulatory legislation. I think a concern which, at least from my
point ofview, comes out ofour experience with regard to radia-
tion standards and is still being debated with regard to guidelines
and regulations with respect to recombinant DNA is the question
oflocal options, local controls versus federal preemption. I won-
der if panelists would like to comment on that.
STANLEY COERR: We don't draft legislation. Our legislation
is clear. We set national standards. That debate was done in the
Congress and they'll keep debating it there, but, I've never got-
ten into that.
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